Talal Using $7 Million Grant to Study Opioid-Related Infections

Updated June 24, 2016

UB researchers have received $7 million in federal funding to expand drug treatment to hundreds of patients throughout New York State, with the research to be led by Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition and director of the Center for Clinical Care and Research in Liver Disease, who will study the spread of hepatitis C virus among drug users who share needles.